Tang, Xiao-Fang <br/><br/>
Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials.  [electronic resource] 

 -  Atherosclerosis  Apr 2014 
 - 568-578 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1879-1484 
<br/><br/><label>Standard No.: </label>10.1016/j.atherosclerosis.2014.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--epidemiology<br/>Adenosine--administration & dosage<br/>Adenosine Monophosphate--administration & dosage<br/>Administration, Oral<br/>Clopidogrel<br/>Coronary Artery Disease--complications<br/>Coronary Restenosis--prevention & control<br/>Fibrinolytic Agents--adverse effects<br/>Hemorrhage--chemically induced<br/>Humans<br/>Injections, Intravenous<br/>Multicenter Studies as Topic--statistics & numerical data<br/>Myocardial Infarction--epidemiology<br/>Piperazines--administration & dosage<br/>Prasugrel Hydrochloride<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Quinazolinones--administration & dosage<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Stents<br/>Stroke--epidemiology<br/>Sulfonamides--administration & dosage<br/>Thiophenes--administration & dosage<br/>Thrombolytic Therapy--adverse effects<br/>Ticagrelor<br/>Ticlopidine--adverse effects